Purchases and Sales Made in Q4 2020 in Celyad Oncology Sa (CYAD)
This table provides information about the institutional ownership of Celyad Oncology Sa (CYAD) during Q4 2020. The information is specifically focused on institutions that hold shares of Celyad Oncology SA.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 12, 2021
Q4 2020
|
Inspire Advisors, LLC
Meridian, ID |
BUY
|
- |
53New |
$378 - $527
|
53
$27.6
|
|
Feb 02, 2021
Q4 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 11, 2021
Q4 2020
|
Ubs Group Ag
|
SELL
|
- |
-209- 29.48% |
$1.49K - $2.08K
|
500
$260
|
|
Feb 09, 2021
Q4 2020
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.7K- 17.06% |
$12.1K - $17K
|
8.28K
$4.31K
|
|
Feb 16, 2021
Q4 2020
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-12.6KClosed |
$90.1K - $126K
|
0
$0
|
|
Feb 01, 2021
Q4 2020
|
Victory Capital Management Inc
|
SELL
|
- |
-44.2K- 5.29% |
$315K - $439K
|
791K
$411K
|